Q3 2023 Arcutis Biotherapeutics Inc Earnings Call Transcript
Good day and welcome to the Arcutis Biotherapeutics Third-Quarter 2023 earnings conference call. (Operator Instructions)
Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Eric McIntyre, Head of Investor Relations. Please go ahead.
Thank you, Abigail, good morning everyone, and thank you for joining us this morning to discuss our Q3 2023 financial results. Slides for today are available on the Investors section of our website. On the call this morning we have Frank Watanabe, President, and CEO; Todd Edwards, our Chief Commercial Officer; Patrick Burnett Chief Medical Officer, and John Smither, our Chief Financial Officer.
I'd remind everyone that we will be making forward-looking statements during this call. These statements are subject to certain risks and uncertainties and our actual results may differ. With that, let me hand the call over to Frank.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |